Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2024-04-24 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
独立董事述职报告（赵强）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2023 by Zhao Qiang, an independent director of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the director's attendance at board meetings, shareholder meetings, independent director meetings, opinions on various board resolutions, and other work related to protecting investor rights. The content focuses on the independent director's duties, meeting participation, and opinions rather than financial data or audit results. It is a formal report on board/management activities and governance oversight by an independent director, not a financial report, audit report, or regulatory announcement. Therefore, it fits best under Board/Management Information (MANG). The document length is 3144 characters, which is relatively short but contains substantive content about board activities and director duties, not just an announcement or certification. Hence, the classification is MANG with high confidence.
2024-04-24 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2024 年第一季度报告" which translates to "2024 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on significant changes and events during the quarter. The report explicitly states it is unaudited and covers the period from January to March 2024. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. There is no indication that this is merely an announcement or a certification, and the document length and content confirm it is the full report itself, not just a notice or summary. Q1 2024
2024-04-24 Chinese
关于2023年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a special report on the storage and actual use of raised funds for the year 2023 by Beijing Yingtai Jiahe Biotechnology Co., Ltd. It references regulatory guidelines from the China Securities Regulatory Commission and the Beijing Stock Exchange, and details the management, usage, and supervision of funds raised through a public stock issuance. The document includes detailed financial figures on the raised funds, their allocation, usage progress, and compliance with relevant laws and regulations. It also contains verification opinions from the sponsor institution and an accounting firm. The content is focused on the specific use and management of raised capital, which aligns with a specialized report on fundraising activities rather than a general annual or interim financial report. The document length is over 5,000 characters and contains substantive financial data and analysis related to capital raising and usage. Therefore, the document fits the category of a Capital/Financing Update (CAP).
2024-04-24 Chinese
2023年年度权益分派预案暨落实“提质守信重回报”行动公告
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the 2023 annual profit distribution plan (dividend distribution) of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes specifics about the dividend amount, the basis for distribution, recent dividend history, legal and procedural compliance, and board and supervisory committee approvals. The document does not contain full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). It is not a simple announcement of a report publication but a substantive disclosure about dividend distribution plans and related corporate governance matters. This fits the definition of a Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and details for shareholders. The document length is 3142 characters, which is consistent with a detailed dividend notice rather than a full annual report or other extensive filings.
2024-04-24 Chinese
关于召开2023年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a notice announcing the convening of the 2023 Annual General Meeting (AGM) of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting date, voting methods, agenda items to be discussed, and procedural information for shareholders. It references the 2023 Annual Report and other reports that have been published separately on the Beijing Stock Exchange information platform, indicating that this document itself is not the annual report but a meeting notice. The document length is 3410 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2024-04-24 Chinese
四川华信（集团）会计师事务所（特殊普通合伙）关于北京颖泰嘉和生物科技股份有限公司2023年度非经营性资金占用及其他关联资金往来情况专项审核说明
Regulatory Filings
2024-04-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.